Suggestions
Rob Menzies
Scientist and people coach. R&D Director at AstraZeneca.
Rob Menzies is a Senior Director at AstraZeneca.2 He is a Scientist and People Coach.2 Rob Menzies works in the Bioscience Renal division, specifically in Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D at AstraZeneca in Gothenburg, Sweden.1 He has been involved in research on chronic kidney disease (CKD) treatments, particularly studying the effects of combining endothelin A receptor antagonists (ET ARA) with sodium-glucose co-transporter 2 inhibitors (SGLT2i).1
Research Contributions
Menzies has contributed to studies investigating the potential benefits of combining zibotentan (an ET ARA) with dapagliflozin (an SGLT2i) in treating CKD. His research has focused on:
- Examining how this combination might mitigate fluid retention risks associated with ET ARA use1
- Exploring the effects on hematocrit and body weight as indicators of fluid retention1
- Contributing to preclinical studies that support further clinical investigation of combination treatments for CKD1
His work aims to advance potential new therapeutic options for patients with chronic kidney disease, addressing both efficacy and safety concerns in drug development.
Highlights
𝐎𝐮𝐫 𝐩𝐥𝐚𝐧𝐞𝐭 𝐚𝐧𝐝 𝐨𝐮𝐫 𝐡𝐞𝐚𝐥𝐭𝐡 𝐚𝐫𝐞 𝐢𝐧𝐭𝐞𝐫𝐭𝐰𝐢𝐧𝐞𝐝
Incredible claims require incredible data and this latest report from Mark R. Miller and colleagues at the World Heart Federation is an eye opener:
𝐊𝐞𝐲 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
- Over 𝟐 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐩𝐞𝐨𝐩𝐥𝐞 remain overly reliant on fuels like wood and coal, exacerbating health risks
- An estimated 𝟕𝟎% 𝐨𝐟 𝟒.𝟐 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐝𝐞𝐚𝐭𝐡𝐬 due to ambient air pollution were from heart disease and stroke
- Particulate matter (PM2.5) levels declined by just 𝟏% 𝐚𝐧𝐧𝐮𝐚𝐥𝐥𝐲 from 2010 to 2019, still higher than the WHO's recommended levels
- 𝐌𝐮𝐥𝐭𝐢𝐦𝐨𝐫𝐛𝐢𝐝𝐢𝐭𝐲 𝐚𝐧𝐝 𝐒𝐞𝐧𝐞𝐬𝐜𝐞𝐧𝐜𝐞: Older adults and those with multiple chronic conditions are particularly vulnerable to the effects of air pollution, leading to higher mortality rates
Link to full report : https://lnkd.in/ddTe68B2 #WorldHeartReport #AirPollution #CardiovascularHealth #GlobalHealth #WHF #EnvironmentalImpact
This week I had the great pleasure of kicking off the industry session at the Keystone Symposia on Molecular & Cellular Biology - Unravelling Vascular Layers to Understand Human Disease - hosted by the Buck Institute for Research on Aging in Novato California.
Thank you Rachel and Stephanie for the invitation to present our latest high impact research at AstraZeneca and for bringing together an innovative new meeting format with academia and industry.
I’m a big fan of this focused meeting style with every presenter highlighting hot-off the press and fresh out of the lab data. Great science from a superb network of world-class researchers.
